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Identification of Intestinal-Type Barrett’s Metaplasia by
Using the Intestine-Specific Protein Villin and Esophageal
Brush Cytology
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Department of Surgery, Section of Thoracic Surgery, University of Michigan Medical School, Ann Arbor, Michigan
Villin is an actin-binding cytoskeletal protein required for brush-border formation in the normal small intes-
tinal and renal proximal tubule epithelium. Villin is a marker of cell differentiation in small intestinal and renal
cell lineages, and recent studies have shown villin to be highly expressed in 100% of intestinal-type Barrett’s
metaplasias. This epithelium is the single greatest risk factor for developing esophageal adenocarcinoma and
arises when the normal esophageal squamous epithelium is replaced by a small intestine–like columnar epithe-
lium after damage by chronic gastroesophageal reflux. In intestinal-type Barrett’s metaplasia, the villin protein
exhibits a highly characteristic staining pattern in which strong apical, brush-border staining of columnar epi-
thelial cells is observed. In this study, the ability to identify intestinal metaplastic cells by using this distinct villin
staining pattern was examined in endoscopic esophageal brushings from patients with confirmed Barrett’s
metaplasia. Esophageal brushings from 81% (17 of 21) of patients with Barrett’s metaplasia demonstrated
individual columnar cells with the characteristic villin staining pattern, whereas all normal esophageal squa-
mous cells, blood cells, and gastric columnar cells were negative for villin expression. Northern blot analysis
demonstrated villin mRNA expression in Barrett’s metaplasia but not in the normal squamous esophagus or
gastric mucosa from the same patients. The combined use of villin immunohistochemical analysis and esoph-
ageal brush cytology may provide a simple and effective method of detecting intestinal-type Barrett’s meta-
plasia in patients at higher risk for developing this epithelium, such as those experiencing chronic
gastroesophageal reflux symptoms. Mol. Carcinog. 24:137–143, 1999. © 1999 Wiley-Liss, Inc.
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INTRODUCTION
Over the past two decades, the incidence of esoph-
ageal adenocarcinoma in the United States has in-
creased at a rate surpassing that of any other cancer
[1]. The main risk factor involved in the develop-
ment of esophageal adenocarcinoma is the presence
of intestinal-type Barrett’s metaplasia [2]. Patients
with Barrett’s metaplasia are 30 to 40 times more
likely to develop adenocarcinoma than the general
population, although the key factors underlying the
progression of Barrett’s metaplasia to adenocarci-
noma remain less well characterized [3]. Intestinal-
type Barrett’s metaplasia results when the normal
stratified squamous epithelium of the esophagus is
destroyed during chronic gastroesophageal reflux and
is replaced by a columnar epithelium containing
characteristic goblet cells [2]. Other types of esoph-
ageal injury, such as atrophic gastritis, caustic injury,
bile reflux, and perhaps chemotherapy, may precede
this metaplastic process [4,5]. In addition, approxi-
mately 12% of patients suffering from chronic gas-
troesophageal reflux disease develop Barrett’s
metaplasia [6].
To facilitate early detection of malignancies, pa-
tients with Barrett’s metaplasia are often enrolled in
endoscopic surveillance programs. Early detection of
esophageal adenocarcinoma is essential because
esophageal cancers are often diagnosed at advanced
stages when metastasis has already occurred, and the
prognosis at that point is usually grim [7]. Currently,
there are no available methods that allow for the
reliable identification of patients with gastroesoph-
ageal reflux disease who have developed premalig-
nant intestinal-type Barrett’s metaplasia, aside from
endoscopy and biopsy. These procedures do involve
a slight risk of complication, such as esophageal per-
foration, and their costs may exclude some patients
with Barrett’s metaplasia from surveillance programs,
leaving these patients undiagnosed. The use of mark-
ers specific for the intestinal-type Barrett’s epithe-
lium would be of great value, especially if combined
with the more accessible procedure of esophageal
brush cytology.
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We have demonstrated the high-level expression
of several intestine-specific gene products in Barrett’s
metaplasia and esophageal adenocarcinomas that are
absent in normal esophageal tissue. The enzyme su-
crase isomaltase was found to be expressed at high
levels in over 80% of patients with Barrett’s meta-
plasia [8]. Aminopeptidase N, an intestinal brush-
border hydrolase, is also highly expressed in Barrett’s
metaplasia [9], and recently we confirmed the spe-
cific and high-level expression of the cytoskeletal
protein villin in 100% of the intestinal-type Barrett’s
metaplasia cases examined [10]. Moreover, villin’s
localization pattern in Barrett’s metaplasia (confined
to the brush border and thus the apical surface) is
quite similar to the pattern found in normal intesti-
nal epithelium, yet villin is not expressed in normal
esophageal squamous epithelium [11]. These results
suggest that villin is a marker specific for intestinal-
type Barrett’s metaplasia and may prove useful in
identifying patients with chronic reflux symptoms
who may have this premalignant epithelium.
Villin is a Ca2+-regulated actin-binding protein lo-
cated in the epithelial cell brush-border of the nor-
mal intestine and proximal tubules of the kidney,
where it is required for apical microvilli formation
[12]. The villin protein is the first brush-border en-
zyme to be concentrated near the apical membrane
during embryonic development and plays a vital role
in villus structure formation [13]. In humans, villin
expression is highly regulated during embryogenesis
and adulthood, and it has been suggested that villin
may be used as a marker of differentiation in renal
and digestive cell development [14]. In addition, the
villin protein has been detected in renal cell carci-
nomas [15]; in gastric, colonic, and pancreatic can-
cers [16]; and in the serum of patients with colorectal
carcinoma [17].
Identification of patients with intestinal-type
Barrett’s metaplasia is vital because of their higher
risk for developing esophageal malignancies. Autopsy
studies have indicated that the incidence of Barrett’s
metaplasia may be even higher than previously rec-
ognized [18]. Villin is a highly specific protein marker
that may prove helpful in identifying patients with
intestinal-type Barrett’s metaplasia who might oth-
erwise remain undiagnosed. In this study, we exam-
ined the immunohistochemical detection of
individual columnar cells that express villin in en-
doscopic esophageal brushings. These brushings were
obtained either at the time of surveillance or during
preoperative endoscopy from patients with con-
firmed Barrett’s metaplasia. Cytopathological analy-
sis and villin immunohistochemical results were then
compared to determine whether this method could
identify Barrett’s metaplastic cells in these patients.
Northern blot analysis of mRNA from normal esopha-
gus, Barrett’s metaplasia, and normal gastric tissues
obtained from the same patients demonstrated the
specific expression of the villin gene in Barrett’s
metaplasia, and western blot analysis confirmed the




Informed consent was obtained from 31 patients
(24 male and seven female; mean age of 56.4 yr) who
underwent treatment at the University of Michigan
Medical Center. Esophageal brushings were obtained
from patients either while they were enrolled in a
surveillance endoscopy program or during endoscopy
before esophagectomy for cancer. Brushings of two
areas of grossly appearing Barrett’s metaplasia were
applied to poly-L-lysine–coated microscope slides and
then stored at –20°C. To obtain additional esopha-
gus and gastric tissue brushings for controls, freshly
resected normal esophagus and gastric tissues from
patients undergoing esophagectomy for cancer were
transported to the laboratory in Dulbecco’s modi-
fied Eagle’s medium on ice. The tissues were lightly
brushed with a small plastic-bristle brush, and the
cells were placed on poly-L-lysine–coated slides and
stored at –20°C until used.
Samples of normal esophagus, Barrett’s metapla-
sia, and normal gastric tissue were obtained after
informed consent from five patients undergoing
esophagectomy for cancer at the Medical Center.
These specimens were transported to the laboratory
as described above, and a portion of each specimen
was frozen in liquid nitrogen. The specimens were
stored at –70°C until used for cryostat sectioning,
immunocytochemical analysis, and protein and RNA
isolation.
Immunohistochemical Analysis
The localization and staining pattern of villin was
determined by immunohistochemical analysis with
an anti-villin monoclonal antibody (Chemicon Intl.,
Inc., Temecula, CA). Five-micrometer cryostat sec-
tions of tissues and esophageal brushings were briefly
air dried and then fixed in 100% acetone at –20°C
for 10 min. All of the following incubations were
performed inside a humidified incubation chamber.
Endogenous peroxidase activity was quenched by
four incubations with a 0.5% H2O2 solution in phos-
phate-buffered saline (PBS) for 20 min each. The
slides were rinsed in PBS three times for 5 min each
time and then incubated with a 1:20 dilution of nor-
mal horse serum in PBS plus 1% bovine serum albu-
min (BSA) for 30 min to block nonspecific binding.
The samples were then incubated with a 1:100 dilu-
tion of the primary anti-villin antibody in PBS plus
1% BSA for 1 h at room temperature. The horse se-
rum blocking solution was substituted for the pri-
mary antibody on negative controls. The slides were
rinsed three times in PBS for 5 min each and incu-
bated with a 1:1000 dilution of goat anti-mouse
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biotinylated secondary antibody in PBS plus 1% BSA
for 30 min. After three additional washes in PBS, the
bound antibody was detected by using the ABC com-
plex method (Vectastain ABC system; Vector Labs,
Inc., Burlingame, CA) as recommended by the manu-
facturer. A 0.1% solution of 3,3′-diaminobenzidine
in PBS served as a chromogen. The slides were lightly
counterstained with hematoxylin, and the presence
of villin-positive cell staining was assessed by two
independent reviewers who were blinded to the iden-
tity of each sample.
Western Blot Hybridization
Protein was extracted from intestinal-type Barrett’s
metaplasia by detergent lysis in a buffer containing
1% Triton X-100, 10 mM Tris-HCl, 150 mM NaCl, 5
mM EDTA, and 10% glycerol. Twenty micrograms
of tissue protein was mixed with an equal volume of
sample buffer (125 mM Tris-HCl, 150 mM NaCl, 5
mM EDTA, 640 mM β-mercaptoethanol, 20% glyc-
erol, 4% sodium dodecyl sulfate (SDS), and 0.2% bro-
mophenol blue). The samples were heat-denatured
and separated by electrophoresis in 7.5% SDS–poly-
acrylamide gels alongside pre-stained low-molecu-
lar-weight markers (Bio-Rad Laboratories, Richmond,
CA). The proteins were transferred to nylon mem-
branes and then incubated for 60 min in a blocking
solution containing 0.1% Tween 20, 100 mM Tris
base, 0.9% NaCl, and 3% powdered milk. The mem-
branes were then incubated with a 1:200 dilution of
the anti-villin monoclonal antibody (Chemicon Intl.,
Inc.) and then with a 1:2000 dilution of biotinylated
goat anti–mouse immunoglobulin G. The avidin-bi-
otin complex method and a mouse immuno-
detection kit (Vectastain ABC system) were used to
detect the villin protein. A 0.1% 3,3′-diamino-
benzidine solution was used as a chromogen, allow-
ing visualization of the villin protein band.
Northern Blot Hybridization
Total cellular RNA was extracted from frozen nor-
mal esophagus, intestinal-type Barrett’s metaplasia,
and normal gastric tissue by using Trizol reagent as
recommended by the manufacturer (Life Technolo-
gies, Gaithersburg, MD). Ten micrograms of each
RNA sample was size fractionated by electrophoresis
in 1.2% agarose gels containing 2.2 M formaldehyde.
The samples were then vacuum-transferred to nylon
membranes (Gene Screen Plus; NEN, Wilmington,
DE), and the membranes were prehybridized in 5×
standard saline phosphate with EDTA (0.9 M NaCl,
50 mM NaPO4 pH 7.7, 5 mM EDTA), 5× Denhardt’s,
3% dextran sulfate, 3% SDS, 50% formamide, 100
µg/ml heat-denatured salmon-sperm DNA, and 25
µg/ml yeast tRNA for 1–2 h at 48°C. The villin cDNA
was obtained by using primers derived from pub-
lished cDNA villin sequences; the 5′ primer was 5′-
CCACAGAGATGCCTGACTTC-3′, and the 3′ primer
was 5′-GAGGTTTTGTTCCTTCCATCG-3′ [14,19].
These villin-specific primers are located in the cod-
ing region for the villin protein head piece. The ex-
pected polymerase chain reaction product of 563 bp
was obtained and gel-purified, and the sequence was
confirmed by automated DNA sequencing at the Se-
quencing Core Facility at the University of Michi-
gan. The villin cDNA probe was labeled with
[32P]dCTP (Amersham Corp., Arlington Heights, IL)
by the random primer-labeling method (Life Tech-
nologies). Unincorporated [32P]dCTP was removed by
Sephadex G-50 exclusion chromatography, and 1.5
× 106 cpm/ml cDNA probe was hybridized with the
membrane in a 48°C shaking water bath for 16 h.
The membranes were washed twice in 2× standard
saline citrate and 1% SDS at 60°C for 20 min each
time and then twice in 0.1× standard saline citrate
at room temperature for 30 min each time. Auto-
radiograms were prepared by using x-ray film (Hyper-
film-MP; Amersham Corp.) and intensifying screens.
Hybridization band intensities were quantified by
scanning laser densitometry (Molecular Dynamics,
Inc., Sunnyvale, CA), and loading and transfer were
assessed by rehybridization of the blots with an oligo
probe specific for the 28S ribosomal RNA as previ-
ously described [20].
RESULTS
Villin Expression and Staining Patterns in
Esophageal Brushings
Previous analyses performed in our laboratory dem-
onstrated the abundant expression of the villin pro-
tein in 100% of Barrett’s intestinal metaplasia [10].
The characteristic villin staining pattern observed in
intestinal-type Barrett’s metaplasia was intense brush-
border staining of the columnar epithelium apical
surface (Figure 1A). This distinct pattern of villin
expression illustrates the staining pattern we ex-
pected to find among the individual columnar epi-
thelial cells from brushings of patients with
intestinal-type Barrett’s metaplasia. In contrast, no
villin expression was detected in cryostat sections of
either normal esophageal squamous epithelium or
gastric tissue (Figure 1A and B).
Villin was observed in the esophageal brushings
of 81% (17 of 21) of patients who were confirmed to
have the diagnosis of Barrett’s metaplasia at the time
of endoscopy or had previously been documented
as having this metaplastic mucosa. The characteris-
tic brush-border villin staining present in the intes-
tinal-type Barrett’s columnar epithelium was also
observed among individual columnar cells from the
brushings of all these patients (Figure 1C, D, and E).
Neither the normal esophageal squamous cells nor
any of the often abundant blood cells present, how-
ever, demonstrated villin staining (Figure 1C). Groups
of Barrett’s cells also stained positive for villin, and
when aggregates of Barrett’s mucosa cells were viewed
from the apical surface end on, a honeycomb-like
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Figure 1. Villin expression in cryostat sections of normal
esophageal squamous epithelium, Barrett’s esophagus and nor-
mal gastric mucosa and in brushings of normal squamous epi-
thelium and Barrett’s metaplasia. (A) Normal squamous mucosa
(s) demonstrates no expression of villin, whereas well-organized,
brush-border staining (arrows) is observed in the intestinal-type
Barrett’s metaplasia. (B) No staining for villin was detected in
normal gastric tissue (g) in either the surface or glandular cells.
(C) Esophageal brushings demonstrating that fried egg–shaped
normal squamous mucosal cells (s, arrows) show no expression
of villin and are easily discernible from the villin-positive co-
lumnar cells. (D) Esophageal brushings of Barrett’s metaplasia
containing columnar cells showing basally located nuclei and
strong apical brush-border staining (arrows) similar to that
observed in cryostat sections of Barrett’s metaplasia. (E and F)
The honeycomb-like villin staining pattern (arrow) formed by
aggregates of columnar epithelial cells in brushings of Barrett’s
metaplasia. The cells shown in panel F are oriented to show
the apical ends, and a mesh-like distribution of villin is appar-
ent in some cells (arrow). All sections and brushings were lightly
counterstained with hematoxylin. Magnifications: panels A and
B, 100×; panels C–F, 200×.
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appearance of villin-stained columnar epithelial cells
was observed (Figure 1F). As shown, on the apical-
most end of the cells, either a light meshwork of villin
or the absence of staining except for a ring-like struc-
ture was often observed.
The brushings from only 154% (three of 21) of pa-
tients with a prior diagnosis of Barrett’s metaplasia
exhibited columnar epithelial cells that were nega-
tive for villin expression or exhibited low levels of
atypical diffuse staining near the apical membrane.
One patient’s brushings lacked any discernible co-
lumnar epithelial cells (5%). Brushings from all four
patients who had not been diagnosed with Barrett’s
intestinal metaplasia were negative for villin stain-
ing. The staining results from the brushings of two
patients whose medical records were inconclusive as
to the diagnosis of Barrett’s metaplasia demonstrated
the diffuse atypical staining mentioned above and
were deemed negative for villin. Brushings of four
normal esophagus and four normal gastric tissue
samples were negative for villin expression as well.
To confirm the specificity of the monoclonal anti-
body used for detecting villin in the brushings, west-
ern blot analysis of samples of intestinal-type Barrett’s
metaplasia was examined by using the anti-villin
antibody. As shown in Figure 2, an intensely stain-
ing band of 95 kDa, which is consistent with the
known size of the villin protein, and a lighter-stain-
ing smaller band were observed.
Villin Gene Expression
Columnar cells exhibiting either atypical or nega-
tive staining for villin might represent gastric or gas-
tric-like columnar epithelial cells present in the
esophageal brushings. To determine whether expres-
sion of the villin gene is confined to Barrett’s meta-
plasia, northern blot analysis of the normal
esophagus, intestinal-type Barrett’s metaplasia, and
gastric tissue from five patients was performed. Nor-
mal human ileum served as a positive control for
villin mRNA expression. Villin mRNA was abundant
in all samples of Barrett’s intestinal metaplasia and
demonstrated the two 3.5- and 2.7-kb mRNAs that
were identical in size and of similar proportion to
those present in the normal ileum (Figure 3). In con-
trast, villin mRNA was not detected in either the
normal esophagus or gastric tissue of any patient.
This demonstrates that the villin gene is not ex-
pressed in the normal esophagus or normal gastric
mucosa to any appreciable extent, and thus it is un-
likely these tissues would contribute villin-positive
stained cells to the esophageal brushings.
DISCUSSION
The results of these analyses are consistent with
those of the two previous examinations of the ex-
Figure 2. Western blot analysis of villin protein expression
in Barrett’s metaplasia. A band corresponding to the 95-kDa
villin protein was detected in the samples of Barrett’s metapla-
sia (B). M, pre-stained molecular weight marker.
Table 1. Summary of Villin Protein Expression in Esophageal Brushings
Brushings No. of cases examined No. villin positive
Confirmed Barrett’s esophagus 21 17 (81%)*
No Barrett’s esophagus 4 0 (0%)
Non-confirmed Barrett’s esophagus† 2 0 (0%)
Normal esophagus 4 0 (0%)
Normal gastric 4 0 (0%)
*The brushings of one patient diagnosed with intestinal-type Barrett’s metaplasia contained no discernable columnar epithelial cells, and the
patient was grouped among the negative villin cases.
†Brushings from patients whose pathology reports indicated the inability to confirm the columnar cells as representing Barrett’s metaplastic cells.
Figure 3. Northern blot analysis of villin mRNA in normal
esophageal squamous mucosa (N), Barrett’s metaplasia (B), and
normal gastric mucosa (G). Results from four of the five pa-
tients are shown. Villin mRNAs of 3.5 and 2.7 kb identical to
those of the normal ileum (I) are present in all samples of
Barrett’s metaplasia but not in either the normal esophageal
or gastric mucosa. The signal from the 28S rRNA is shown in
the bottom panel.
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pression and localization of the villin protein in in-
testinal-type Barrett’s metaplasia [10,11]. Villin’s
high-level, characteristic brush-border expression
makes it a promising candidate for an intestine-spe-
cific marker that may be used to detect intestinal-
type Barrett’s metaplasia in patients at high risk for
developing this metaplasia. We observed that in the
esophageal brushings of 81% of patients with
prediagnosed intestinal-type Barrett’s metaplasia,
there were individual columnar epithelial cells that
expressed villin. The strong apical staining observed
in the brushed cells closely resembles the character-
istic villin staining pattern detected in cryostat sec-
tions of intestinal-type Barrett’s epithelium and small
intestinal mucosa [10,11]. Blood cells, normal esoph-
ageal squamous cells, and gastric-type columnar epi-
thelial cells displayed no villin staining, so the
villin-positive Barrett’s columnar epithelial cells were
easily distinguished when these other cells were
present in the brushings.
The absence of villin immunoreactivity in the gas-
tric mucosa and gastric brushings may suggest an
explanation for the negative staining results observed
in the brushings of 14% (three of 21) of the patients
with preexisting Barrett’s metaplasia. It is possible
that cells from the gastric cardias or esophagogastric
junctions of these three patients were brushed in-
stead of cells from the areas of intestinal-type Barrett’s
metaplasia, producing brushings that consisted
mostly of gastric-type columnar epithelial cells.
Northern blot analysis demonstrated that gastric
mucosa does not express the villin gene. This is con-
sistent with our immunohistochemical results, which
showed that villin protein was not detectable in gas-
tric columnar cells. Although brushings from these
three patients did not demonstrate the characteris-
tic strong brush-border staining, it is also possible
that either low-level or altered villin protein was
present in the columnar epithelial cells. Altered villin
localization may have given rise to the low-level,
atypical diffuse staining observed, which was scored
as negative for villin expression in this study. Sev-
eral factors may alter the cellular localization of the
villin protein in the brushings, including repeated
freezing and thawing of the brushing slides or expo-
sure to excessive moisture before staining.
It is therefore necessary to establish objective cri-
teria with which to evaluate the staining and expres-
sion patterns of villin protein in the individual
columnar epithelial cells obtained from esophageal
brushings of patients at risk for developing Barrett’s
metaplasia. In this study, the independent review-
ers classified the esophageal brushings as positive
only when multiple areas of cells demonstrating
highly expressed and distinct brush-border villin
staining of columnar cells were present. Villin-posi-
tive cells viewed from the side exhibited a basally
located nucleus and a strong band of staining at the
apical surface. Aggregates of columnar cells oriented
with their apical sides facing the viewer stained as
distinct rings that resembled either honeycombs or
net-like structures. As described above, any low-level
immunoreactivity that appeared diffuse, grainy, cy-
toplasmic, or otherwise nonspecific was scored as
negative for villin expression. Filamentous staining
in large aggregates of cells was attributed to trapped
primary antibody and was also considered a nega-
tive result.
The use of esophageal brush cytology in conjunc-
tion with villin immunohistochemical analysis may
provide a simple yet effective means for identifying
patients with intestinal-type Barrett’s metaplasia
among those patients who are at an increased risk
for developing this condition due to chronic reflux
symptoms. This procedure could be useful as a pre-
liminary screening method for patients, with con-
firmatory endoscopy and biopsy following if
villin-positive columnar cells consistent with Barrett’s
metaplasia are detected. Unlike endoscopy, the
brushing procedure can be performed without seda-
tion during a routine visit to the physician’s office,
perhaps by using a nasogastric tube or by balloon
cytology [21]. Although this procedure will undoubt-
edly not replace the need for confirmatory endos-
copy and biopsy, its greatest use may be to help
identify the presence of intestinal metaplasia in these
high-risk individuals. Because villin is strongly and
characteristically expressed in individual columnar
epithelial cells of intestinal-type Barrett’s metapla-
sia, these results suggest that this technique may be
most useful for identifying intestinal-type metapla-
sia in patients with chronic gastroesophageal reflux
symptoms who may be at risk for developing this
premalignant mucosa. Future studies will examine
the efficacy of this technique relative to the known
extent of Barrett’s mucosa present in these patients,
because it is very likely that extensive Barrett’s mu-
cosa would be more easily detected. However, given
the sensitivity of this procedure, even individual
villin-positive columnar cells should be detectable
in patients with small segments of Barrett’s mucosa.
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